Glenmark Pharmaceuticals: A healthy bet
Focus on low-risk complex generics and speciality products are key positives
Indian pharma companies, caught in regulatory tangles and squeezed by pricing pressure in key markets, have been facing tough times of late. In particular, companies focussing on the US market have been hit hard. Such concerns have turned investors away from pharma stocks. But the steep correction in stock prices offers a good buying opportunity for investors with a long two to three-year time hor...
Read the rest of this article by Signing up for Portfolio.
It's completely free!
SIGN UP NOW
Investment alerts,End of day market reports, Market news analysis,External research reports and Technical calls
Daily update on Business and Market news via email
'Your Market Corner' Widget with personalized business and market news